PROGYNY INC (PGNY) Stock News
NASDAQ:PGNY - Nasdaq - US74340E1038 - Common Stock - Currency: USD
PGNY Latest News, Press Relases and Analysis
Progyny Adds Pelvic Floor Therapy, Continuing to Close Gaps in Care Across Women’s Health
With nearly one third of women impacted by pelvic floor disorders, expanded care access and education from Progyny will help eliminate the silent...
Progyny Adds Pelvic Floor Therapy, Continuing to Close Gaps in Care Across Women’s Health
With nearly one third of women impacted by pelvic floor disorders, expanded care access and education from Progyny will help eliminate the silent suffering
GDRX vs. PGNY: Which Stock Should Value Investors Buy Now?
GDRX vs. PGNY: Which Stock Is the Better Value Option?
Mentions: GDRX
Progyny Stock Trades Higher On Collaboration With Amazon’s Health Benefits Connector: Retail’s Yet To Be Impressed
Through Amazon’s Health Benefits Connector, eligible individuals can now seamlessly enroll in Progyny benefits that are available to them through their employer or health plan.
Progyny Joins Amazon’s Health Benefits Connector Program as First Women’s Health and Family Building Solution
The collaboration will enable Amazon customers who are eligible for Progyny services to discover and enroll in fertility, family building, and menopause benefits.
Progyny Joins Amazon’s Health Benefits Connector Program as First Women’s Health and Family Building Solution
The collaboration will enable Amazon customers who are eligible for Progyny services to discover and enroll in fertility, family building, and menopause...
Progyny Adds Distinguished Healthcare Executive Elizabeth Bierbower to Board of Directors
Progyny Adds Distinguished Healthcare Executive Elizabeth Bierbower to Board of Directors
NEW YORK, May 29, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced...
Progyny Appoints Two Renowned Women’s Health Experts to Medical Advisory Board
Medical Advisory Board additions support company’s growing product offerings across women’s health and family building
Progyny Appoints Two Renowned Women’s Health Experts to Medical Advisory Board
Medical Advisory Board additions support company’s growing product offerings across women’s health and family building...
Progyny, Inc. to Present at BofA Securities 2025 Health Care Conference
NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced...
Progyny (PGNY) Tops Q1 Earnings and Revenue Estimates
Progyny (PGNY) delivered earnings and revenue surprises of 6.67% and 6.60%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: DOCS
Progyny, Inc. Announces First Quarter 2025 Results
Progyny, Inc. Announces First Quarter 2025 Results
Reports Record Revenue of $324.0 Million, Reflecting 16.5% GrowthRaises Full Year Guidance Due to Strong Start to the YearEarly Selling Season Activity...
Solventum Q1 Earnings Likely to Reflect Higher Costs & Expenses
SOLV's Q1 performance is likely to have been hurt by below-par revenue growth in several markets, coupled with currency headwinds. Improved pricing might have offset the sales decline.
Will Applied Sterilization Growth Help STE Beat Q4 Earnings Estimates?
STERIS is expected to have experienced an increase in bioprocessing demand in the fourth quarter.
MCK Stock Up 24% YTD: Should You Buy, Hold or Sell Before Q4 Earnings?
McKesson's fourth-quarter fiscal 2025 results are likely to reflect the solid display by the U.S. Pharmaceutical and Specialty Solutions segment, driven by higher prescription volume.
Progyny (PGNY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Progyny (PGNY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Mentions: CRL
Progyny, Inc. Announces Details for Its First Quarter 2025 Results Report
Progyny, Inc. Announces Details for Its First Quarter 2025 Results Report
NEW YORK, April 24, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building, will report its...
Progyny Names Healthcare Veterans Melissa Cummings as Chief Operating Officer and Geoffrey Clapp as Chief Product Officer
The leadership additions support the company’s continued ability to scale as it delivers the right care model for women’s health and family building
Progyny Names Healthcare Veterans Melissa Cummings as Chief Operating Officer and Geoffrey Clapp as Chief Product Officer
The leadership additions support the company’s continued ability to scale as it delivers the right care model for women’s health and family building...
Progyny to Host Events Honoring Individuals, Families and Infertility Throughout National Infertility Awareness Week® and Canadian Fertility Awareness Week®
As awareness around the need for expanded access and coverage of fertility grows, Progyny lifts off the conversation and provides a platform for the...
Progyny to Host Events Honoring Individuals, Families and Infertility Throughout National Infertility Awareness Week® and Canadian Fertility Awareness Week®
As awareness around the need for expanded access and coverage of fertility grows, Progyny lifts off the conversation and provides a platform for the millions of individuals facing family building challenges
The Broken Brown Egg and Progyny Announce the 2025 Awareness, Hope, and Activism Grant™ to Support BIPOC Individuals and Couples in Family Building
NEW YORK, April 08, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, and The...